Literature DB >> 16711008

Effects of 17beta-estradiol on the expression of IL-6, IL-11 and NF-kappaB in human MG-63 osteoblast-like cell line.

Yunlin Wang1, Eyuan Liao, Guangda Xiang, Ruchun Dai, Xinhua Xiao, Xianghang Luo.   

Abstract

In order to characterize the effects of 17beta-estradiol (17beta-E2) on the expression of IL-6, IL-11 and NF-kappaB in the human MG-63 osteoblast-like cell line, the expression of IL-6 was detected by RT-PCR, Northern blot and Western blot. The expression of IL-11 was determined by RT-PCR, and NF-kappaB by Western blot. The results showed that 17beta-E2 down-regulated the expression of IL-6 mRNA and protein, IL-11 mRNA and NF-kappaB protein in MG-63 cells. It was suggested that the expression of NF-kappaB, IL-6 and IL-11 in MG-63 cells could be suppressed by 17beta-E2, and this might lend support to estrogen replacement therapy in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16711008     DOI: 10.1007/bf02828038

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

1.  Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro.

Authors:  Q Qu; P L Härkönen; J Mönkkönen; H K Väänänen
Journal:  Bone       Date:  1999-08       Impact factor: 4.398

2.  The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.

Authors:  L C Hofbauer; R M Ten; S Khosla
Journal:  J Bone Miner Res       Date:  1999-08       Impact factor: 6.741

Review 3.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro.

Authors:  U S Masiukiewicz; M Mitnick; A B Grey; K L Insogna
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

5.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

6.  Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice.

Authors:  K Black; I R Garrett; G R Mundy
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

7.  Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression.

Authors:  A Dovio; M L Sartori; R G Masera; S Racca; A Angeli
Journal:  Cytokine       Date:  2001-07-07       Impact factor: 3.861

8.  Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling.

Authors:  T Yamamoto; T Matsuda; A Junicho; H Kishi; F Saatcioglu; A Muraguchi
Journal:  FEBS Lett       Date:  2000-12-08       Impact factor: 4.124

9.  Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors.

Authors:  M Kassem; S A Harris; T C Spelsberg; B L Riggs
Journal:  J Bone Miner Res       Date:  1996-02       Impact factor: 6.741

10.  The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.

Authors:  E Romas; N Udagawa; H Zhou; T Tamura; M Saito; T Taga; D J Hilton; T Suda; K W Ng; T J Martin
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

View more
  1 in total

1.  Effect of Oxidative Stress-Induced Apoptosis on Active FGF23 Levels in MLO-Y4 Cells: The Protective Role of 17-β-Estradiol.

Authors:  Vladana Domazetovic; Irene Falsetti; Simone Ciuffi; Teresa Iantomasi; Gemma Marcucci; Maria Teresa Vincenzini; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.